AASLD Raises Concern Over Removal of Evidence-Based Alcohol Guidance in 2025–2030 Dietary Guidelines for Americans
The American Association for the Study of Liver Diseases (AASLD) expresses deep concern over the 2025–2030 Dietary Guidelines...
The American Association for the Study of Liver Diseases (AASLD) expresses deep concern over the 2025–2030 Dietary Guidelines...
On January 7, 2026, the Department of Health and Human Services (HHS) and the Department of Agriculture (USDA) released updated...
AASLD develops evidence-based practice guidelines which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. AASLD also provides practice tools to assist with learning and implementing the new recommendations.
Dr. Elizabeth Verna is the Frank Cardile Associate Professor of Medicine at Columbia University Irving Medical Center, where she practices as transplant hepatologist. Dr. Verna has an active clinical research program in end-stage liver disease and liver transplantation and is the Director of Clinical Research for the Columbia University Transplant Clinical Research Center as well as the Director of Hepatology Research for the Division of Digestive and Liver Diseases.
In 2025, AASLD advanced science, strengthened education, shaped public policy, expanded global engagement, and brought the...
Adult Liver Transplantation: Candidate Evaluation and Adult Liver Transplantation: Diagnosis and Post-Transplant Management of...
ALEXANDRIA, Virginia — The American Association for the Study of Liver Diseases (AASLD) is pleased to announce the appointment...
The American Association for the Study of Liver Diseases (AASLD) and its undersigned partner organizations, American College of...
New guidance provides clinicians with practical, evidence-based criteria for patient selection, comorbidity management, and...
The American Association for the Study of Liver Diseases (AASLD) acknowledges the recent market withdrawal of obeticholic acid...